Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Ocugen (OCGN) R&D In Process (2020)

Ocugen (OCGN) has disclosed R&D In Process for 1 consecutive years, with $7.0 million as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, R&D In Process changed N/A year-over-year to $7.0 million, compared with a TTM value of $7.0 million through Sep 2021, changed N/A, and an annual FY2020 reading of $7.0 million, changed N/A over the prior year.
  • R&D In Process was $7.0 million for Q3 2020 at Ocugen.
  • Across five years, R&D In Process topped out at $7.0 million in Q3 2020 and bottomed at $7.0 million in Q3 2020.